๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
SciVision Biotech Inc. (TPE:1786)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
40.35
-1.35 (-3.24%)
Nov 20, 2026, 1:30 PM CST

SciVision Biotech Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
870.41886.62883.31712.99557.35505.54
Revenue Growth
-2.25%0.38%23.89%27.93%10.25%8.28%
Gross Profit
614.78638.39655.68512.49371.87341.84
Operating Income
132.83189.92248.11199.64134.61121.94
Net Income
142.82162.34242.25177.9141.72101.72
Earnings Per Share
1.902.183.302.411.921.51
EPS Growth
-15.10%-34.03%37.15%25.26%27.30%-20.11%

Revenue by Segment

Fiscal Year
FY 2025FY 2024
Period EndingDec '25 Dec '24
Adjustment and Elimination
-32.56-17.35
Medical Device Manufacturing Department
852.27881.23
Beauty Management Service Department
66.9219.43
Total
886.62883.31

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
871.11925.71805.92745617.73695.84
Total Debt
485.56485.13224.24347.91411.99633.09
Net Cash (Debt)
385.56440.57581.69397.09205.7462.75
Net Cash Growth
-18.65%-24.26%46.49%93.01%227.89%-31.96%
Net Cash Per Share
4.945.737.815.192.760.88

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
97.37123.99269.87272.01181.9998.51
Capital Expenditures
-101.53-101.53-34.76-14.73-14.96-25.78
Free Cash Flow
-4.1622.46235.11257.28167.0372.73
Free Cash Flow Growth
--90.45%-8.62%54.04%129.64%21.97%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
70.63%72.00%74.23%71.88%66.72%67.62%
Operating Margin
15.26%21.42%28.09%28.00%24.15%24.12%
Pretax Margin
18.37%20.87%33.01%29.45%31.14%22.96%
Profit Margin
16.41%18.31%27.43%24.95%25.43%20.12%
FCF Margin
-0.48%2.53%26.62%36.08%29.97%14.39%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.9101.9103.2502.5002.0001.420
Dividend Per Share Growth
-66.20%-41.23%30.00%25.00%40.84%60.49%
Dividend Yield
4.73%2.73%3.13%3.22%3.69%2.86%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
21.2432.2830.8229.5425.3232.28
Forward PE
-19.1216.1020.8520.8520.85
P/FCF Ratio
-233.3231.7620.4221.4845.14
PS Ratio
3.475.918.457.376.446.49